Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by MTPConnect. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MTPConnect or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

How the UK’s Subscription-Style Model is Improving Access to Much-Needed Antibiotics

17:05
 
Share
 

Manage episode 452283202 series 3009792
Content provided by MTPConnect. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MTPConnect or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Send us a text

As World Antimicrobial Resistance Awareness Week (WAAW) kicked off around the globe, the Australian Antimicrobial Resistance Network (AAMRNet) was meeting in Canberra to explore how Australia can better support the development of and access to new antimicrobial technologies.

Key clinicians, researchers, industry and government representatives gathered to discuss how a subscription-style funding model for new antimicrobials might be adapted to be fit-for-purpose in Australia.

It’s an idea turned into reality by the UK’s National Health Service (the NHS) after it successfully piloted a world-first subscription reimbursement model, with the goal to improve access to much needed antibiotics, and at the same time incentivize the pharmaceutical industry to develop new antibiotics to tackle superbugs.

David Glover, Assistant Director of Medicines Analysis at NHS England joined the workshop to explain the UK model in detail.

Afterwards he had a chat with Caroline Duell for the MTPConnect Podcast about the impetus for this pioneering approach, why paying manufacturers a fixed fee for antimicrobials can boost drug development and why this UK model, which is now being expanded, benefits governments, companies and patients.

  continue reading

193 episodes

Artwork
iconShare
 
Manage episode 452283202 series 3009792
Content provided by MTPConnect. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MTPConnect or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Send us a text

As World Antimicrobial Resistance Awareness Week (WAAW) kicked off around the globe, the Australian Antimicrobial Resistance Network (AAMRNet) was meeting in Canberra to explore how Australia can better support the development of and access to new antimicrobial technologies.

Key clinicians, researchers, industry and government representatives gathered to discuss how a subscription-style funding model for new antimicrobials might be adapted to be fit-for-purpose in Australia.

It’s an idea turned into reality by the UK’s National Health Service (the NHS) after it successfully piloted a world-first subscription reimbursement model, with the goal to improve access to much needed antibiotics, and at the same time incentivize the pharmaceutical industry to develop new antibiotics to tackle superbugs.

David Glover, Assistant Director of Medicines Analysis at NHS England joined the workshop to explain the UK model in detail.

Afterwards he had a chat with Caroline Duell for the MTPConnect Podcast about the impetus for this pioneering approach, why paying manufacturers a fixed fee for antimicrobials can boost drug development and why this UK model, which is now being expanded, benefits governments, companies and patients.

  continue reading

193 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play